| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |